Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.

Payne NL, Sylvain A, O'Brien C, Herszfeld D, Sun G, Bernard CC.

N Biotechnol. 2015 Jan 25;32(1):212-28. doi: 10.1016/j.nbt.2014.05.001. Review.

PMID:
24815224
2.

Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.

Liu Y, Deng W.

Brain Res. 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Review.

PMID:
26423934
3.

The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.

Peng J, Zeng X.

Stem Cell Res Ther. 2011 Jul 28;2(4):32. doi: 10.1186/scrt73. Review.

4.

Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.

Jung YW, Hysolli E, Kim KY, Tanaka Y, Park IH.

Curr Opin Neurol. 2012 Apr;25(2):125-30. doi: 10.1097/WCO.0b013e3283518226. Review.

5.

Neurodegenerative disease-specific induced pluripotent stem cell research.

Inoue H.

Exp Cell Res. 2010 Oct 1;316(16):2560-4. doi: 10.1016/j.yexcr.2010.04.022. Review.

PMID:
20420829
6.

Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.

Cao L, Tan L, Jiang T, Zhu XC, Yu JT.

Mol Neurobiol. 2015 Aug;52(1):244-55. doi: 10.1007/s12035-014-8867-6. Review.

PMID:
25146848
7.

Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.

Gao A, Peng Y, Deng Y, Qing H.

Neuroscience. 2013 Jan 3;228:47-59. doi: 10.1016/j.neuroscience.2012.09.076. Review.

PMID:
23069758
8.

Bioengineered stem cells in neural development and neurodegeneration research.

Yuan SH, Shaner M.

Ageing Res Rev. 2013 Jun;12(3):739-48. doi: 10.1016/j.arr.2013.04.002. Review.

9.

Neural stem cell-based treatment for neurodegenerative diseases.

Kim SU, Lee HJ, Kim YB.

Neuropathology. 2013 Oct;33(5):491-504. doi: 10.1111/neup.12020. Review.

PMID:
23384285
10.

Induced pluripotent stem cells and neurodegenerative diseases.

Chen C, Xiao SF.

Neurosci Bull. 2011 Apr;27(2):107-14. doi: 10.1007/s12264-011-1147-9. Review.

PMID:
21441972
11.

Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.

Corti S, Faravelli I, Cardano M, Conti L.

Expert Opin Drug Discov. 2015 Jun;10(6):615-29. doi: 10.1517/17460441.2015.1037737. Review.

PMID:
25891144
12.

Current status of treating neurodegenerative disease with induced pluripotent stem cells.

Pen AE, Jensen UB.

Acta Neurol Scand. 2017 Jan;135(1):57-72. doi: 10.1111/ane.12545. Review.

PMID:
26748435
13.

Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.

Skalova S, Svadlakova T, Shaikh Qureshi WM, Dev K, Mokry J.

Int J Mol Sci. 2015 Feb 13;16(2):4043-67. doi: 10.3390/ijms16024043. Review.

14.

Research on neurodegenerative diseases using induced pluripotent stem cells.

Imamura K, Inoue H.

Psychogeriatrics. 2012 Jun;12(2):115-9. doi: 10.1111/j.1479-8301.2011.00394.x. Review.

15.

Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration.

Chambers SM, Mica Y, Studer L, Tomishima MJ.

Methods Mol Biol. 2011;793:87-97. doi: 10.1007/978-1-61779-328-8_6.

PMID:
21913095
16.

[Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].

Ito D, Yagi T, Suzuki N.

Brain Nerve. 2013 Mar;65(3):283-8. Review. Japanese.

PMID:
23475520
17.

Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.

Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X.

Stem Cells. 2010 Oct;28(10):1893-904. doi: 10.1002/stem.499.

18.

Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.

Xu X, Huang J, Li J, Liu L, Han C, Shen Y, Zhang G, Jiang H, Lin Z, Xiong N, Wang T.

Cell Prolif. 2016 Feb;49(1):14-26. doi: 10.1111/cpr.12229. Review.

PMID:
26748765
19.

Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy.

Yamashita T, Abe K.

Cell Transplant. 2014;23(4-5):435-9. doi: 10.3727/096368914X678274. Review.

PMID:
24621988
20.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O.

Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.

Items per page

Supplemental Content

Support Center